VISONE, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 3.502
EU - Europa 2.606
AS - Asia 2.051
Continente sconosciuto - Info sul continente non disponibili 275
SA - Sud America 243
AF - Africa 31
OC - Oceania 3
Totale 8.711
Nazione #
US - Stati Uniti d'America 3.434
SG - Singapore 814
IT - Italia 657
CN - Cina 527
DE - Germania 336
IE - Irlanda 273
UA - Ucraina 260
VN - Vietnam 228
TR - Turchia 215
GB - Regno Unito 212
RU - Federazione Russa 207
BR - Brasile 193
SE - Svezia 177
FI - Finlandia 173
FR - Francia 157
IN - India 106
HK - Hong Kong 37
CA - Canada 31
BE - Belgio 26
NL - Olanda 25
BD - Bangladesh 24
AT - Austria 21
AR - Argentina 20
KR - Corea 19
MX - Messico 19
PL - Polonia 17
JP - Giappone 16
ES - Italia 14
IQ - Iraq 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
ZA - Sudafrica 11
UZ - Uzbekistan 9
CH - Svizzera 8
GR - Grecia 7
LT - Lituania 7
RO - Romania 7
SA - Arabia Saudita 5
AZ - Azerbaigian 4
CO - Colombia 4
CR - Costa Rica 4
IR - Iran 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
AU - Australia 3
CL - Cile 3
DZ - Algeria 3
ID - Indonesia 3
IL - Israele 3
JM - Giamaica 3
PH - Filippine 3
PK - Pakistan 3
TH - Thailandia 3
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CU - Cuba 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
MM - Myanmar 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
IM - Isola di Man 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 8.438
Città #
Singapore 584
San Jose 378
Chandler 349
Dallas 311
Jacksonville 304
Dublin 271
Ashburn 218
Chieti 217
Munich 202
Council Bluffs 148
Beijing 145
Princeton 124
Southend 124
Dearborn 122
Izmir 111
Ann Arbor 108
Helsinki 101
Los Angeles 87
The Dalles 79
Ho Chi Minh City 70
Nanjing 67
Santa Clara 64
Hanoi 62
Wilmington 58
Cambridge 45
Pescara 45
New York 44
Tongling 42
Boardman 36
Hong Kong 30
Rome 27
Altamura 26
Redondo Beach 26
Buffalo 25
Woodbridge 23
Brussels 22
Nanchang 21
Washington 20
Montesilvano Marina 19
Orem 19
Dong Ket 18
São Paulo 18
Brooklyn 16
Jiaxing 16
Seoul 16
Hefei 15
London 15
Moscow 15
Tokyo 15
Vienna 15
Hebei 14
Shenyang 14
Amsterdam 12
Carini 12
Chicago 12
Columbus 12
Denver 11
Houston 11
Kunming 11
Tianjin 11
Toronto 11
Da Nang 10
Jinan 10
Jyväskylä 10
Mexico City 10
Warsaw 10
Frankfurt am Main 9
Guangzhou 9
Manchester 9
Nuremberg 9
Ancona 8
Ankara 8
Atlanta 8
Changsha 8
Collecorvino 8
L'aquila 8
Leawood 8
Montreal 8
Mumbai 8
Orsogna 8
Stockholm 8
Brno 7
Charlotte 7
Haiphong 7
Johannesburg 7
Milan 7
Poplar 7
Seattle 7
Tashkent 7
Belo Horizonte 6
Lappeenranta 6
Shanghai 6
Teramo 6
Turku 6
Ascoli Piceno 5
Grevenbroich 5
Hangzhou 5
Hải Dương 5
Ningbo 5
Quito 5
Totale 5.354
Nome #
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 262
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 259
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib 256
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. 241
A POSSIBLE ROLE OF A CMV-LIKE VIRUS IN HEAD AND NECK PARAGANGLIOMA PATHOGENESIS 222
Possible role of a CMV-like virus in paragangliomas 212
A developmental perspective on paragangliar tumorigenesis 204
A developmental model of paragangliar tumorigenesis highlights therapeutic targets 198
Hsa-miR-200 and hsa-miR34 miRNA family members target cellular and viral genes regulating HCMV infection in head and neck paraganglioma 190
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 173
Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation 172
MiR-181b in Chronic Lymphocytic Leukemia B Cells Is Regulated By Cellular Interaction with CD4+ T Cells and Increases the CTL Toxicity Versus the Leukemic Clone 171
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 158
Impact of BCR Stimulation on Mir-181b in Chronic Lymphocityc Leukemia 156
Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells 155
Epigenetics and microRNAs in cancer 146
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 142
Hnrnpl restrains MIR-155 targeting of BUB1 to stabilize aberrant karyotypes of transformed cells in chronic lymphocytic leukemia 142
MicroRNAs in autoimmunity and hematological malignancies 142
B-RAF mutations are a rare event in pituitary adenomas. 140
Reprogramming of miRNA networks in cancer and leukemia. 138
PDGFRA is controlled by miRNAs in head and neck paraganglioma cells: in vitro and in vivo treatment with imatinib mesylate. 137
A perspective analysis: microRNAs, glucose metabolism, and drug resistance in colon cancer stem cells 137
E2F1 activation is responsible for pituitary adenomas induced byHMGA2 gene overexpression 136
A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy 136
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 134
Deregulation of microRNA expression infollicular cell-derived human thyroidcarcinomas 133
Karyotype-specific microRNA signature in chronic lymphocytic leukemia. 126
Oncogenic role of miR-483-3p at the IGF2/483 locus. 126
The glucose-regulated MiR-483-3p influences key signaling pathways in cancer 125
UCbase & miRfunc: a database of ultraconservedsequences and microRNA function 124
Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells 123
Tagging enhances histochemical and biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin 123
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas 122
A microRNA expression signature of humansolid tumors defines cancer gene targets 121
MiR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 119
Critical Role of the HMGA2 Gene in Pituitary Adenomas 118
Genechip Microarray analysis of pituitary adenomas developed by HMGA transgenic mice 118
A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas 117
Critical role of the RB-E2F pathway in the generation of pituitary adenomas in transgenic mice overexpressing the HMGA2 gene 114
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 114
Therapeutic effect of microRNA-15/16 cluster in a mouse model of chronic lymphocytic leukemia 110
Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice 108
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas 106
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 104
Mutated β-catenin evades a microRNA-dependentregulatory loop 103
Genechip microarray analysis of pituitary adenomas developed by HMG transgenic mice. 102
Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophyand Myelo-Lymphoproliferative Disorders in Mice 100
Targeted Disruption of the Murine Homeodomain-InteractingProtein Kinase-2 Causes Growth Deficiency In Vivoand Cell Cycle Arrest In Vitro 100
Ucbase and miRfunc: A database which links ultraconserved sequences and microRNA with cancer and mendelian inheritance human disorders 99
Regulation of microRNA expression by HMGA1 proteins 98
Overexpression of the HMGA2 gene induces mixed growth hormone cell/prolactin cell pituitary adenomas by impairment of the RB/E2F pathway 97
HMGA Proteins Up-regulate CCNB2 Gene in Mouse and HumanPituitary Adenomas 96
MiR-181b: New perspective to evaluate disease progression in chronic lymphocytic leukemia 95
Targeted disruption of the murine PATZ gene induces growth retardation 94
Overexpression of the HMGA2 gene induces mixed growth hormon cell/prolactin cell pituitary adenomas by impairment of the Rb/E2F pathway 93
Role of microRNAs in Chronic Lymphocytic Leukemia 91
The Mia/Cd-rap gene expression isdownregulated by the high-mobility group Aproteins in mouse pituitary adenomas 91
Identification of microRNA activity by Targets’ ReverseEXpression 91
Generation of vectors that coexpress intronic microRNAs and exonic reporters 90
miR-483-3p is an oncogene involved in nephroblastoma and in adult tumors with activated ß-catenin 89
RANBP9 as potential therapeutic target in non-small cell lung cancer 87
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2) 86
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 86
MiR-181b expression levels decrease during the progression of Chronic Lymphocytic Leukemia: a new potential prognostic tool 81
Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia 27
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation 5
Totale 8.711
Categoria #
all - tutte 31.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022361 0 11 5 44 25 5 29 45 51 14 32 100
2022/2023905 89 106 56 105 95 171 51 73 104 14 29 12
2023/2024454 20 17 48 14 29 134 102 8 2 15 25 40
2024/20251.518 60 185 151 27 29 137 169 125 188 82 158 207
2025/20262.794 193 115 412 326 244 145 538 173 274 181 155 38
2026/2027130 35 95 0 0 0 0 0 0 0 0 0 0
Totale 8.711